Clinical trial
Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal…
NCT00373334 · Braintree Laboratories, Industry · Completed
Key facts
| NCT number | NCT00373334 |
|---|---|
| Title | Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD) |
| Official title | A Double-Blind, Randomized, Parallel, Multicenter Study of Axid (Nizatidine) Oral Solution in the Treatment of Gastroesophageal Reflux Disease (GERD) Symptoms in Infants Age 30 Days-1 Year |
| Lead sponsor | Braintree Laboratories, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux Disease, GERD, Heartburn |
| Intervention type | Drug |
| Interventions | nizatidine (axid), placebo |
| Enrollment | 138 |
| Start date | Aug 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Sep 8, 2006 |
| Last update posted | Nov 18, 2009 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: